Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Cardiovasc. Med.

Sec. Lipids in Cardiovascular Disease

This article is part of the Research TopicAdvancements in Understanding and Managing Residual Risk of Coronary Artery DiseasesView all 6 articles

Association between Triglyceride Levels and Hypertension in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: a Retrospective Cross-Sectional Study

Provisionally accepted
  • 1The Second Affiliated Hospital of Harbin Medical University, Harbin, China
  • 2Harbin Medical University Key Laboratory of Myocardial Ischemia Ministry of Education, Harbin, China
  • 3Hunan University of Medicine General Hospital, Huaihua, China

The final, formatted version of the article will be published soon.

Background: This study aimed to investigate the association between serum triglyceride (TG) levels and the presence of hypertension in patients with coronary artery disease (CAD) and hypertension undergoing percutaneous coronary intervention (PCI). Methods: This retrospective study included 3,150 patients diagnosed with CAD who underwent PCI after coronary angiography (CAG) at the Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, between September 8, 2019, and February 27, 2022. Serum TG levels were measured within 24 h of admission, and covariates, including demographic data, clinical characteristics, and serum biomarkers, were collected. Multivariate logistic regression models were used to analyze the association between TG levels and hypertension. Results: A total of 36.8% (1,159/3,150) were ultimately included in the analysis, with 27.5% (319/1,159) presenting acute myocardial infarction (AMI). After adjusting for multiple confounding factors, TG levels were found to be independently associated with the presence of hypertension (odds ratio [OR]=1.23, 95% confidence interval [CI]: 1.03-1.47). When grouped by TG level quartiles, compared with the Q1 group, Q2, Q3, and Q4 showed significantly higher risks of CAD-related hypertension [OR, 95% CI: 1.98 (1.39–2.81), 1.80 (1.25–2.58), and 2.61 (1.68–4.05), respectively]. Furthermore, an additional analysis revealed a nonlinear relationship between TG and hypertension, characterized by a pronounced saturation effect which was particularly pronounced in patients with ejection fraction < 50%. Conclusion: This study is the first to demonstrate a J-shaped association between TG level and hypertension presence in patients with CAD after PCI, with an inflection point of 3.86 mmol/L. This association was more pronounced in patients with reduced EF, suggesting that in patients with cardiac dysfunction, there is a stronger association between TG levels and hypertension, which may warrant further investigation into the clinical benefits of TG management in this subgroup.

Keywords: Triglycerides, Coronary Artery Disease, Hypertension, Percutaneous Coronary Intervention, J-shaped association

Received: 28 Oct 2025; Accepted: 08 Dec 2025.

Copyright: © 2025 Yu, Hu, Jia, Gao, Gao, Fang, Zhang, Hao and Zhao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Bo Yu
Sining Hu
Haibo Jia

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.